Assenagon Asset Management S.A.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in ARWR
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$16,459,069
+$12,776,385 QoQ
Shares Held
201,927
+243.8% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 497 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. ARWR ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in ARWR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,459,069 | 201,927 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $3,682,684 | 58,735 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $45,469,780 | 684,889 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $13,127,756 | 380,625 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $403,990 | 25,569 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $289,210 | 22,701 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $996,644 | 53,013 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,677,017 | 293,083 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,291,018 | 88,150 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,851,756 | 344,467 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,175,284 | 38,408 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $11,295,395 | 420,372 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $17,750,050 | 497,758 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $10,751,997 | 423,307 | Shares | Sole | 2023-04-18 | |
| 2022-06-30 | $514,734 | 14,619 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $5,964,948 | 129,701 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $554,599 | 8,365 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $755,964 | 12,109 | Shares | Sole | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||